Correlation Between Dermata Therapeutics and Heartbeam Warrant

Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Heartbeam Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Heartbeam Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dermata Therapeutics Warrant and Heartbeam Warrant, you can compare the effects of market volatilities on Dermata Therapeutics and Heartbeam Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Heartbeam Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Heartbeam Warrant.

Diversification Opportunities for Dermata Therapeutics and Heartbeam Warrant

-0.11

Correlation Coefficient

Dermata Therapeutics  Heartbeam Warrant

Good diversification

The 3 months correlation between Dermata and Heartbeam is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics Warrant and Heartbeam Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heartbeam Warrant and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics Warrant are associated (or correlated) with Heartbeam Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heartbeam Warrant has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Heartbeam Warrant go up and down completely randomly.

Pair Corralation between Dermata Therapeutics and Heartbeam Warrant

Assuming the 90 days horizon Dermata Therapeutics Warrant is expected to generate 2.1 times more return on investment than Heartbeam Warrant. However, Dermata Therapeutics is 2.1 times more volatile than Heartbeam Warrant. It trades about 0.18 of its potential returns per unit of risk. Heartbeam Warrant is currently generating about 0.13 per unit of risk. If you would invest  1.00  in Dermata Therapeutics Warrant on September 22, 2024 and sell it today you would earn a total of  0.47  from holding Dermata Therapeutics Warrant or generate 47.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	38.98%
Values	Daily Returns

Dermata Therapeutics Warrant  vs.  Heartbeam Warrant

Dermata Therapeutics

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Dermata Therapeutics Warrant are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Dermata Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Heartbeam Warrant

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Heartbeam Warrant are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Heartbeam Warrant showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dermata Therapeutics and Heartbeam Warrant

The main advantage of trading using opposite Dermata Therapeutics and Heartbeam Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Heartbeam Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heartbeam Warrant will offset losses from the drop in Heartbeam Warrant's long position.

The idea behind Dermata Therapeutics Warrant and Heartbeam Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.